<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><description>It takes nothing to join the crowd, but it takes everything to stand alone</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 12 Mar 2021 11:24:20 +0800</pubDate><image><url>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</url><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>新药从研发到上市的全流程</title><link>https://mp.weixin.qq.com/s/9-JS0R9wTFydf2qvlHcROA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia9Spo0XfGibTAiaLMCNkniaGibUiafMnicpnuXr0AHeMuq7pEe2wlic38JJia6B5hHaW5bH0BkG44lJkmicpibQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sat, 06 Mar 2021 22:06:41 +0800</pubDate></item><item><title>快讯 | NMPA发布《医疗器械应急审批程序（修订稿征求意见稿）》</title><link>https://mp.weixin.qq.com/s/dM6qgXWp18u5AlQPuzUynA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia9Spo0XfGibTAiaLMCNkniaGibUbJXUeEfZjzBdtic3DSMc5gdTp3uEee8WiaC2Vgj9pA2tI9OfkibvicSHJg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sat, 06 Mar 2021 22:06:41 +0800</pubDate></item><item><title>速度似闪电！治疗糖尿病新药问世，仅用57天就在中国成功上市</title><link>https://mp.weixin.qq.com/s/Gtwp5FIsra64EAZFqyrzHg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia9Spo0XfGibTAiaLMCNkniaGibUH4rulBnbZhmyHWoLVanGtgav1icHdr9rLaUtgk2y4UCiaGhLTSoSJH2w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sat, 06 Mar 2021 22:06:41 +0800</pubDate></item><item><title>免疫系统——人体的防御保卫军</title><link>https://mp.weixin.qq.com/s/ughdhdO2FfVn6lMOWYQbLg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia9Spo0XfGibTAiaLMCNkniaGibUia7Q1u4Mnc4gwhlMz7A7TM5hDE3QicB5gxcNLGgc1mic0JughrvyAAT9A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sat, 06 Mar 2021 22:06:41 +0800</pubDate></item><item><title>科技进展 | NMPA批准第12个国产小分子激酶抑制剂伏美替尼上市，全球第3个三代EGFR抑制剂</title><link>https://mp.weixin.qq.com/s/oc_FkV3a0Y-Fs_lpRzTuhg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUiaibrJ700kswCWvGJKEewb6CkKUOzbufultele9CYII4UDEobHE6apMpkibcia7lJrvCvP45JYIv7UqWA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Fri, 05 Mar 2021 18:24:05 +0800</pubDate></item><item><title>肿瘤免疫中的NK细胞</title><link>https://mp.weixin.qq.com/s/_bYm2QM1ChYEX1einVtZNQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUiaibrJ700kswCWvGJKEewb6CkJKmnzOF5WqXTYNicrPN1taQeYm9feXrnsOacSJ3z5lqh9MUEvHaW5Zg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Fri, 05 Mar 2021 18:24:05 +0800</pubDate></item><item><title>《中国药典》2020年版第四部通用技术要求增修订概况</title><link>https://mp.weixin.qq.com/s/s7YgA-sgH-SR8tKoe6-H1g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUiaibrJ700kswCWvGJKEewb6Ck2RDCxarmpkFIzPGYjdhJZSpkCNFZKrpwfImoA1zBm0gJZ21Wh2gK6Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Fri, 05 Mar 2021 18:24:05 +0800</pubDate></item><item><title>【洞见】肺癌靶点全面解读及对应靶向治疗药物盘点！</title><link>https://mp.weixin.qq.com/s/auQm7RvKxLyDgehJ9MkedA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUiaibrJ700kswCWvGJKEewb6CkqzPxwpBt7fFnZFtKQ1RYsxBGWNrJ8sx9qUE8AAHeS8icv7qNnHxxGXA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>肿瘤是人类健康的“杀手”，免疫治疗与靶向治疗的联合应用将成为未来发展趋势。]]></content:encoded><pubDate>Fri, 05 Mar 2021 18:24:05 +0800</pubDate></item><item><title>Ⅳ期原发性肺癌中国治疗指南（2021年版）权威发布！</title><link>https://mp.weixin.qq.com/s/Ztk_k-hCz_1TR4qJ9GjwDA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUiaibMxcQ8b8uicGfxT8rgNpnAsdgaBQVak9JZoIBiaGQrUgGflYejj9nnhzB9JUdcRmRk5FMD7BIJjwSg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Thu, 04 Mar 2021 22:31:50 +0800</pubDate></item><item><title>CAR-T系列之复制型病毒安全风险评估及控制</title><link>https://mp.weixin.qq.com/s/BN6HhzE7eqVSbZ0ofAYsDQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUiaibMxcQ8b8uicGfxT8rgNpnAsj9RlMyKe6borfhHsgHjn6xHRXqfiaxw0CzAzbiaYTS7DWFhMYjAlWcSg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>​RCR/RCL是CAR-T细胞治疗产品一个安全性质量控制项目，因病毒载体设计的不同，产生RCR/RCL的风险也会有不同，如采用四质粒共转体系以及含有末端自我失活结构，慢病毒载体在生产过程中产生RCR/RCL的风险会明显降低]]></content:encoded><pubDate>Thu, 04 Mar 2021 22:31:50 +0800</pubDate></item><item><title>图说| 关于注射剂一致性评价的药学要求</title><link>https://mp.weixin.qq.com/s/tZHFEjzLAnSJ0bat2Ae4AQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUiaibMxcQ8b8uicGfxT8rgNpnAskl5HOPVZyuJia8RjChf11ryRB9oNoia81mx2Np4QjxH5u9RSFxY6AV4A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>注射剂，药学研究是重点]]></content:encoded><pubDate>Thu, 04 Mar 2021 22:31:50 +0800</pubDate></item><item><title>行业政策|2020年国内干细胞相关政策汇总，相关产业值得期待！</title><link>https://mp.weixin.qq.com/s/yeubq3jbJo2uu2XPZQnExA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia89Ljnp8Q0sgjnGQTUbkODSLLhQhoSavCYzd1miaIDL2L6Lbd0hWBTJ2NEgs20LTR32XJG9FVeeanA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Wed, 03 Mar 2021 22:02:26 +0800</pubDate></item><item><title>原料药关键工艺参数的研究思路解析</title><link>https://mp.weixin.qq.com/s/Iu1WNKpjxyLW3m39CljKXg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia89Ljnp8Q0sgjnGQTUbkODS0QpgCMGfgNs99aibzeO4OmqzjDRLTdHibm94Qyn4uZEFIJhDDOL7gmsQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Wed, 03 Mar 2021 22:02:26 +0800</pubDate></item><item><title>国外2020年61个单抗产品销售额总计已超1500亿美元</title><link>https://mp.weixin.qq.com/s/7lv92vlqtJxkRrcejlr2Kw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia89Ljnp8Q0sgjnGQTUbkODSl2z8L0Bu2e0jQTvs2tH0Fx8mibzXgK31QHTXZdh77VKNwzcLQOUEbLA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>最近，随着各大公司年报的逐渐出炉，笔者汇总整理了国外61个抗体药物的2020年最新销售数据和其他年度数据。]]></content:encoded><pubDate>Wed, 03 Mar 2021 22:02:26 +0800</pubDate></item><item><title>​【精选】专利视角下石墨烯在生物医药领域的研究进展</title><link>https://mp.weixin.qq.com/s/09OG5888ktzynbDSF2ggaw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia89Ljnp8Q0sgjnGQTUbkODSX3IicD0Lf6iafY4j67eZL6h5mOuXbV3uZmBoTPQdbxn3mhicJib05cSYvQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Wed, 03 Mar 2021 22:02:26 +0800</pubDate></item><item><title>强生腺病毒载体新冠疫苗FDA申报紧急上市答辩PPT</title><link>https://mp.weixin.qq.com/s/ziAhHp7r4Ts5O9a3RoRwDg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia9zNibibZSxDiamGSEDE0yzlmJPzeJLWkZSDheiafrF84wNAT8a6JpBRrU7oXMBMpLho5GfSicSdLKcyug/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Tue, 02 Mar 2021 19:24:49 +0800</pubDate></item><item><title>NMPA综合司再次公开征求《疫苗生产流通管理规定（征求意见稿）》意见</title><link>https://mp.weixin.qq.com/s/Fl82giLVN0vPO6p-uucdZg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia9zNibibZSxDiamGSEDE0yzlmJ5aR99YaHqOUCQV5nCDTYJsaGagOKfcUiavxlEs5LAAGgvricB9Fic7yRA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Tue, 02 Mar 2021 19:24:49 +0800</pubDate></item><item><title>某药监局发布《药品生产监督检查缺陷整改指南》！</title><link>https://mp.weixin.qq.com/s/Mv6GZ8UhBp1Pp_6RGcZEjQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia9zNibibZSxDiamGSEDE0yzlmJakH7kELK1T7A7gxjf9E3ohmAl7l33zZGqh8ySjE7icf2270ua62GiczQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Tue, 02 Mar 2021 19:24:49 +0800</pubDate></item><item><title>李宾讲临床丨方案设计与风险规避</title><link>https://mp.weixin.qq.com/s/md2rBzwTDSMyqQ2pHWOeOg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia9zNibibZSxDiamGSEDE0yzlmJ8B9uLHzNicBQaNhIgiacJAVI6oTFM7mJ5NyYwf5BBcV16JyicX167dibFQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>风险管理的理念应该贯穿方案设计的始终。]]></content:encoded><pubDate>Tue, 02 Mar 2021 19:24:49 +0800</pubDate></item></channel></rss>